Related Articles
Research
Oppenheimer Initiates Odyssey Therapeutics at Outperform With $40 Price Target
$ODTX
Research
Cantor Fitzgerald Initiates Odyssey Therapeutics at Overweight
$ODTX
Research
Truist Downgrades Taylor Morrison Home to Hold From Buy Following Deal Announcement, Keeps $72.50 Price Target
Taylor Morrison Home (TMHC) has an average rating of hold and mean price target of $70, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$TMHC